Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission
- PMID: 33547747
- PMCID: PMC8014094
- DOI: 10.1002/cyto.a.24315
Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission
Abstract
During the second surge of COVID-19 in France (fall 2020), we assessed the expression of monocyte CD169 (i.e., Siglec-1, one of the numerous IFN-stimulated genes) upon admission to intensive care units of 45 patients with RT-PCR-confirmed SARS-CoV2 pulmonary infection. Overall, CD169 expression was strongly induced on circulating monocytes of COVID-19 patients compared with healthy donors and patients with bacterial sepsis. Beyond its contribution at the emergency department, CD169 testing may be also helpful for patients' triage at the ICU to rapidly reinforce suspicion of COVID-19 etiology in patients with acute respiratory failure awaiting for PCR results for definitive diagnosis.
Keywords: CD169; COVID-19; monocyte; sepsis.
© 2021 International Society for Advancement of Cytometry.
Conflict of interest statement
This study was partially supported by Beckman Coulter through donation of the CD169 reagents used in the study. This private company had no role in the study design, or collection and interpretation of the clinical data.
Figures


References
-
- Bourgoin P, Soliveres T, Ahriz D, Arnoux I, Meisel C, Unterwalder N, et al. Clinical research assessment by flow cytometry of biomarkers for infectious stratification in an Emergency Department. Biomark Med. 2019;13:1373–86. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous